Bisindolylmaleimide IX facilitates extrinsic and initiates intrinsic apoptosis in TNF-α-resistant human colon adenocarcinoma COLO 205 cells

Apoptosis

Volumn 13, Issue 4, 2008, Pages 509-522

  Pajak, Beata ^a   Turowska, Agnieszka ^b   Orzechowski, Arkadiusz ^a,b   Gajkowska, Barbara ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Bisindolylmaleimides; cFLIP; Colon cancer; Immune escape; TNF

Indexed keywords

BISINDOLYLMALEIMIDE; BISINDOLYLMALEIMIDE IX; CYTOCHROME C; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FLICE INHIBITORY PROTEIN; PROCASPASE 9; PROTEIN BCL 2; PROTEIN BID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL FRACTIONATION; CELL VIABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MITOCHONDRION; PRIORITY JOURNAL; ULTRASTRUCTURE; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 9; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; INDOLES; MALEIMIDES; PROTEIN KINASE C; STAUROSPORINE; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 41149180460     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-008-0194-9     Document Type: Article

References (34)

1. Jacobson MD, Weil M, Raff M (1997) Programmed cell death in animal development. Cell 88:347-354
2. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME (1998) Apoptosis signaling by death receptors. Eur J Biochem 254:439-459
3. French L, Tschopp J (1999) Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J Exp Med 190:891-893
4. Zong W-X, Edelstein LC, Chen C, Bash J, Gelinas C (1999) The prosurvival homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev 13:382-387
5. Xiao CW, Asselin E, Tsang BK (2002) Nuclear factor κB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor α-induced apoptosis in rat granuloma cells. Biol Reprod 67:436-441
6. Fulda S, Meyer E, Debatin KM (2000) Metabolic inhibitors sensitize for CD95 (APO-1/Fas) induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1 converting enzyme inhibitory protein expression. Cancer Res 60:3947-3956
7. Pajak B, Gajkowska B, Orzechowski A (2005) Cycloheximide-mediated sensitization to TNF-α-induced apoptosis in human colorectal cancer cell line COLO 205; role of FLIP and metabolic inhibitors. J Physiol Pharmacol 56(Supp 3):101-118
8. Hernandez A, Wang QD, Schwartz SA, Evers BM (2001) Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 5:56-65
9. Lippa MS, Srockbina LD, Le TT, Bransteller DG, Strathdee CA, Holland PM (2007) Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells. Apoptosis 12:1465-1478
10. Toullec D, Pianetti P, Coste H et al (1991) The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:1571-1581
11. Bit RA, Davis PD, Elliott LH et al (1993) Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J Med Chem 36:21-29
12. Jacobson PB, Kuchera SL, Metz A, Schachtele C, Imre K, Schrier DJ (1995) Anti-inflammatory properties of Go (6850) a selective inhibitor of protein kinase C. J Pharmacol Exp Therap 275:995-1002
13. Zhou T, Song L, Yang P, Wang Z, Lui D, Jope RS (1999) Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune disease. Nat Med 5:42-48
14. Jacobson MD, Burne JF, Raff MC (1994) Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910
15. McKeague AL, Wilson DJ, Nelson J (2003) Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines. Br J Cancer 88:125-131
16. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254
17. Watts AD, Hunt NH, Madigan MC, Chaudhri G (1999) Soluble TNF-alpha receptors binds and neutralize over-expressed transmembrane TNF-alpha on macrophages, but do not inhibit its processing. J Leukoc Biol 66:1005-1013
18. Han Z, Pantazis P, Lange TS, Wyche JH, Hendrickson EA (2000) The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C. Cell Death Differ 7:521-530
19. Brehmer D, Godl K, Zech B, Wissing J, Daub H (2004) Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors. Mol Cell Proteomics 3:490-500
20. Ward NE, O'Brian CA (1992) Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates. Mol Pharmacol 41:387-392
21. Pajak B, Orzechowski A (2007) Sodium butyrate-dependent sensitization of human colon adenocarcinoma COLO 205 cells to TNF-α-induced apoptosis. J Physiol Pharmacol 58(Supp 3):163-176
22. El Deiry WS (2001) Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling. Cell Death Differ 8:1066-1075
23. Ashkenazi A (2002) Targeting death and decoy receptors of the tumor necrosis factor superfamily. Nat Rev Cancer 2:420-430
24. Micheau O, Solary E, Hammann A, Diamanche-Boitrel MC (1999) Fas-ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem 274:7987-7992
25. Rokhlin O, Glover RA, Taghiyev AF et al (2002) Bisindolylmaleimide IX facilitates tumor necrosis factor receptor family-mediated cell death and acts as an inhibitor of transcription. J Biol Chem 277:33213-33219
26. Daehn IS, Verelias A, Rayner TE (2006) Sodium butyrate induced keratinocyte apoptosis. Apoptosis 11:1379-1390
27. L and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 95:3478-3482
28. Lautrette C, Loum-Ribat E, Petit D, Vermont-Desroches C, Wijdenes J, Jaubertan MO (2002) Increase of Fas-induced apoptosis by inhibition of extracellular phosphorylation of Fas receptor in Jurkat cell line. Apoptosis 11:1195-1204
29. Beltman J, McCormick F, Cook SJ (1996) The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J Biol Chem 271:27018-27024
30. Merritt JE, Sullivan JA, Drew L et al (1999) The bisindolylmaleimide protein kinase C inhibitor Ro 32-2241, reverses multidrug resistance in KB tumor cells. Cancer Chemother Pharmacol 43:371-378
31. Snowden RT, Sun XM, Dyer MJS, Cohen GM (2003) Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1. Leukemia 17:1981-1989
32. MacFarlane M, Harper N, Snowden RT, Dyer MJ, Barnett GA, Pringle JH, Cohen GM (2002) Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia. Oncogene 21:6809-6818
33. Henshall DC, Bonislawski BB, Skradski SL, Lan JQ, Meller R, Simon RP (2001) Cleavage of bid may amplify caspase-8-induced neuronal death following focally evoked limbic seizures. Neurobiol Dis 8(4):568-580
34. Kim R (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103:1551-1560